Loading...

Discover something new with just one click.

Shuffle Most Popular Featured

2014 ACR Annual Meeting

Presentations, Posters, and Papers galore. Check out our ACR 2014 newsroom to learn more about our commitment to rheumatology.

FDA Approval

On November 14, 2014, a Genentech medicine received FDA approval for use in a specific type of platinum-resistant ovarian cancer.

2014 AAO Annual Meeting

Genentech will present important new ophthalmic data at the 118th Annual Meeting of the American Academy of Ophthalmology (AAO) from October 18-21 in Chicago.

FDA Approval

On October 15, 2014, the FDA approved a medicine for the treatment of idiopathic pulmonary fibrosis (IPF).

Genentech Agrees to Acquire Seragon to Strengthen Breast Cancer Pipeline

Read about Genentech’s planned acquisition of Seragon.

New Insights on Breast Cancer Research

With the recent acquisition of Seragon, Genentech is excited to add a new class of investigational medicines known as SERDs to our pipeline.

Sunshine Act: Increasing Transparency

Genentech fully supports efforts to increase transparency around the partnership between the industry and healthcare professionals.

FDA Approval

Medicine for people with chronic idiopathic urticaria (CIU), a form of chronic hives.

Patient Access

Genentech is committed to ensuring price is not a barrier to access for patients. Learn about our programs.

Job Search

Search for jobs. Learn more about what is currently available. And then apply for the position at Genentech that’s right for you.

Clinical Trial Data Sharing

As part of our commitment to sharing data from our clinical trials, researchers may now request access to analyzable patient-level data. Learn more.

Saving Sight

We partnered on a survey that identified a significant gap in the understanding of diabetes and vision loss. Learn more.

Exposing Innovation

We’re working together to shape the future of biotech. Take a look inside Genentech.

Our Pipeline

Our pipeline includes new molecular entities that address serious unmet medical needs.

Collaborating With Managed Care

Insights on trends, events, and therapeutic advances. Learn more at Genentech-Forum.com.